Press release
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investor Notice: Update in Lawsuit
A lawsuit is pending on behalf of investors in Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) shares over alleged securities laws.
Investors who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and for certain investors are short and strict deadlines running. Deadline: November 1, 2021. NASDAQ: SPPI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 31, 2021, a lawsuit was filed against Spectrum Pharmaceuticals, Inc. over securities laws violations. The plaintiff claims that between December 27, 2018 and August 5, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that the ROLONTIS manufacturing facility maintained deficient controls and/or procedures, that the foregoing deficiencies decreased the likelihood that the FDA would approve the ROLONTIS BLA in its current form, that Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
In November 2021, several investors filed motions to be a pointed to represent investors affected by the filed lawsuit.
Those who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investor Notice: Update in Lawsuit here
News-ID: 2539573 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Spectrum
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope:
Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market
In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics …
SAER illuminates with 'Spectrum' his New Single Inspired by encounters with Auti …
Indie Electro Pop-Rock Power Ballad Pays Emotional Tribute to the Complex and Beautiful World of AS.
UK-based alt-pop rock artist SAER and co-writer Paul Griffin are thrilled to announce the upcoming release of SAER's latest single, 'Spectrum', scheduled for Friday, 29th March 2024. This collaboration is deeply rooted in personal experiences with the Autism Spectrum, offering a poignant expression of empathy and a celebration of neurodiversity.
'Spectrum' is profoundly influenced by Griffin's…
Neuromyelitis Optica Spectrum Disorder Market
According to a new market research report published by Global Market Estimates, the Global Neuromyelitis Optica Spectrum Disorder Market is projected to grow at a CAGR of 6.2% from 2023 to 2028.
F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi (France), Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Zydus Cadila, Boehringer Ingelheim International GmbH., Apotex Inc., and AstraZeneca among others, are some of the key players in the global…
Has 5G changed the spectrum price evolution? - Towards more regulatory intervent …
The advent of 5G and the use of medium and higher frequencies have changed the game. Prices seem to have fallen and interventionist actions have increased.
Radio spectrum is a vital asset for MNOs and a key resource for regulators and citizens.
Radio spectrum used by mobile networks (below 3 GHz) has always been scarce, which pushes MNOs to opt for new spectrum usage techniques.
The main reason for spectrum pricing is to…
Cognitive Radio Market Report 2018: Segmentation by Component (Software Tools, H …
Global Cognitive Radio market research report provides company profile for BAE Systems (London, UK), Raytheon Company (Massachusetts, US), Thales Group (Paris, France), Rhode & Schwarz (Munich, Germany), Spectrum Signal Processing (Burnaby, Canada), xG Technology (Florida, US), Nutaq (Quebec, Canada) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Global Spectrum Analyzer Market Share
According to a new report Global Spectrum Analyzer Market (2017-2023), published by KBV Research, the global Spectrum Analyzer Market is expected to attain a market size of $1.7 billion by 2023, growing at a CAGR of 8% during the forecast period.
The Asia Pacific market dominated the Global Spectrum Analyzer in Industry & Energy Sector Market by Region in 2016, and would continue to be a dominant market till 2023; growing…
